Navigation Links
REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body
Date:2/4/2008

cal

remission in adult and pediatric patients with moderately to severely

active CD who have had an inadequate response to conventional therapy.

-- Reducing the number of draining enterocutaneous and rectovaginal

fistulas and maintaining fistula closure in adult patients with

fistulizing CD.

-- Reducing signs and symptoms, inducing and maintaining clinical

remission and mucosal healing, and eliminating corticosteroid use in

patients with moderately to severely active UC who have had an

inadequate response to conventional therapy.

-- Reducing signs and symptoms of active arthritis, inhibiting the

progression of structural damage and improving physical function in

patients with PsA.

-- Treatment of adult patients with chronic severe plaque PsO who are

candidates for systemic therapy and when other systemic therapies are

medically less appropriate.

REMICADE is unique among available anti-TNF biologic therapies. Unlike self-administered therapies that require patients to inject themselves frequently, REMICADE is the only anti-TNF biologic administered directly by caregivers in the clinic or office setting. REMICADE is a two-hour infusion administered every 6 or 8 weeks (indication-dependent), following a standard induction regimen that requires treatment at weeks 0, 2 and 6. As a result, REMICADE patients may require as few as six treatments each year.

Important Safety Information

There are reports of serious infections, including tuberculosis (TB), sepsis and pneumonia. Some of these infections have been fatal. Tell your doctor if you have had recent or past exposure to people with TB. Your doctor will evaluate you for TB and perform a TB test. If you have latent (inactive) TB, your doctor should begin TB treatment before you start REMICADE. REMICADE can lower your ability to fight infections, so if you are prone to or have a h
'/>"/>

SOURCE Centocor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Observational Data Show Transfusion Patterns in Chemotherapy-Induced Anemia Patients Receiving Erythropoiesis-Stimulating Agents
2. TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients
3. JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients
4. Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
5. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
6. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
7. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
8. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
9. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
10. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
11. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... N.C. , April 28, 2015 Chiltern, a ... Year (CRoY) winners in the UK, joining the five finalists ... the Gold Pharma in the CTA category and Helen ... Source professionals are working with Novartis. "We are ... as top performers in the industry," commented Nannette Penny ...
(Date:4/28/2015)... Minn. , April 28, 2015 ANI ... the Company plans to release its first quarter 2015 ... opening of the U.S. financial markets. The earnings press ... of the Company,s website, www.anipharmaceuticals.com . ... Executive Officer, and Charlotte C. Arnold , Vice ...
(Date:4/28/2015)... , April 28, 2015  Rosa & Co. ... drug-disease modeling and simulation, today announced its pleasure to ... exciting field of Quantitative Systems Pharmacology (QSP). The conference ... drug development.  ... Rosa,s lead sponsorship ...
Breaking Medicine Technology:Chiltern expands PharmaTimes Clinical Researcher of the Year involvement as sponsor, host and winner 2Chiltern expands PharmaTimes Clinical Researcher of the Year involvement as sponsor, host and winner 3ANI Pharmaceuticals Schedules Conference Call for First Quarter 2015 Financial Results 2Rosa & Co. is the Lead Partner for the Quantitative Systems Pharmacology (QSP) Congress in Basel, Switzerland and Will Present the Keynote Address 2Rosa & Co. is the Lead Partner for the Quantitative Systems Pharmacology (QSP) Congress in Basel, Switzerland and Will Present the Keynote Address 3
... a,licensee of Vical Incorporated (Nasdaq: VICL ), ... 3 clinical trial of its NV1FGF,angiogenesis therapy, which ... successful completion of the trial, called TAMARIS,sanofi-aventis expects ... The plasmid DNA (pDNA) therapy encodes Fibroblast Growth ...
... division of Wyeth (NYSE: WYE ), presented ... a selective estrogen receptor,modulator, at the American Society ... three-year study, data showed that bazedoxifene 20 mg ... new vertebral fractures by 42,percent and 37 percent, ...
Cached Medicine Technology:Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations 2Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations 3Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis 2Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis 3Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis 4
(Date:4/28/2015)... Md. (PRWEB) April 28, 2015 ... that advances the cause of medical foods and ... Kaycee Childress as the organization’s new executive director. ... face severe health consequences because of conditions and ... natural, life-sustaining diet. To live and thrive, ...
(Date:4/28/2015)... 2015 Board certified dermatologist Dr. ... a new, online acne treatment system that provides ... their specialized acne mapping technology. This online acne ... of California with internet access to receive full-service ... a physical office. The online acne treatment service ...
(Date:4/28/2015)... 2015 2015 Market Research Report ... professional and in-depth research report. The report provides ... overview, industry chain structure, international market analysis, and ... global (US, Europe, Japan, Asia) and Chinese market ... & economic situation analysis. The Global and Chinese ...
(Date:4/28/2015)... Two leaders in patient safety from the ... Hospital Review’s list of 50 Experts Leading the Field ... , director of the Armstrong Institute for Patient ... patient safety and quality at Johns Hopkins Medicine, and ... medical affairs and chief patient safety officer at All ...
(Date:4/28/2015)... Vancouver, BC (PRWEB) April 28, 2015 ... published a blog stating that it is smarter to ... of a personal injury claim. The blog reasons that ... lawyer since these professional are well-versed with the law ... the client would be able to on their own. ...
Breaking Medicine News(10 mins):Health News:Children's Medical Nutrition Alliance (CMNuA) Hires Kaycee Childress as Executive Director 2Health News:New Online Acne Treatment Service for California 2Health News:Centrifuges Market 2015 Global Research Report 2Health News:Centrifuges Market 2015 Global Research Report 3Health News:Johns Hopkins Medicine and All Children’s Hospital Leaders Recognized as Top Experts in Patient Safety 2Health News:Johns Hopkins Medicine and All Children’s Hospital Leaders Recognized as Top Experts in Patient Safety 3Health News:Johns Hopkins Medicine and All Children’s Hospital Leaders Recognized as Top Experts in Patient Safety 4Health News:Vancouver Personal Injury Lawyers Recently Stated in Latest Blog That It Is Smarter To Call A Lawyer Before ICBC 2
... SAN DIEGO, June 16 US Farms, Inc. (Pink Sheets: ... Hispanic focused web site www.jugodealoevera.com , which ... Aloe Vera Juice retails for $14.95 per bottle or wholesales for ... be ordered online with Visa, Master Card, Discover, or American Express ...
... Growing Non-Urban Market Segments , , DENVER, ... Med" or the "Company") (OTC Bulletin Board: GLOB), ... that its Wyndgate Technologies(R) division has licensed its ... hospital healthcare system. The organization will also ...
... , ALEXANDRIA, Va., June 16 Ambulatory surgery centers (ASCs) play a ... concludes a study issued today by the independent health economics and policy ... the growth in the number of ASCs between 2000 and 2007, include: ... ASCs are essential Medicare providers of surgical and cancer ...
... PORT ORANGE, Fla., June 16 Suddenly it happens, with ... find ourselves needing to parent our parents. , , ... to Dance Again," ( published by iUniverse ), ... own experience becoming caretaker for her mother, "She Just Wanted ...
... ... Today, HealthCare California announces that it is the first home health agency ... national leaders to utilize technology to improve health care. This home ... real-time access to information at the point of care, reduces costs, improves ...
... its counterparts in Europe -- , ... for a larger government role in health care and the ... United States may worry some pharmaceutical companies, all should share ... physician prescription decisions in the United States. , , ...
Cached Medicine News:Health News:US Farms, Inc. Launches Aloe Vera Juice Web Site for Hispanic Market 2Health News:US Farms, Inc. Launches Aloe Vera Juice Web Site for Hispanic Market 3Health News:Global Med Technologies(R) Licenses Transfusion Software Solution to Nationwide Healthcare System 2Health News:Global Med Technologies(R) Licenses Transfusion Software Solution to Nationwide Healthcare System 3Health News:Ambulatory Surgery Centers 'Pivotal' in Moving Outpatient Surgical Services Into Less Expensive, Clinically Appropriate Settings 2Health News:Ambulatory Surgery Centers 'Pivotal' in Moving Outpatient Surgical Services Into Less Expensive, Clinically Appropriate Settings 3Health News:Ambulatory Surgery Centers 'Pivotal' in Moving Outpatient Surgical Services Into Less Expensive, Clinically Appropriate Settings 4Health News:Ambulatory Surgery Centers 'Pivotal' in Moving Outpatient Surgical Services Into Less Expensive, Clinically Appropriate Settings 5Health News:'She Just Wanted to Dance Again': Navigate the Exchange of Parent-Caregiving Relationships Through Example, Advice 2Health News:New Online Home Health Service Launched in California to Expand Direct Patient Care Time While Lowering Costs 2Health News:New Online Home Health Service Launched in California to Expand Direct Patient Care Time While Lowering Costs 3Health News:Health Care Reform May Force U.S. Pharmaceutical Companies to Overhaul Sales Strategies, Says New Report From ZS Associates and eyeforpharma 2Health News:Health Care Reform May Force U.S. Pharmaceutical Companies to Overhaul Sales Strategies, Says New Report From ZS Associates and eyeforpharma 3Health News:Health Care Reform May Force U.S. Pharmaceutical Companies to Overhaul Sales Strategies, Says New Report From ZS Associates and eyeforpharma 4Health News:Health Care Reform May Force U.S. Pharmaceutical Companies to Overhaul Sales Strategies, Says New Report From ZS Associates and eyeforpharma 5
... Introducing the new large ... new handpieces function as both ... the ultimate in flexibility. Its ... always wanted with the security ...
... 7600 Oscillating Saw offers unparalleled ... thanks to its 14.4V NiMH ... head may be rotated into ... any plane and will accept ...
... Breakthrough in Battery Powered Orthopedic Systems., ... new addition to the Hall® Surgical line ... System is the first and only software ... market. It is a full-function orthopedic power ...
... Introducing the new large ... Our new handpieces function ... electric instruments, offering the ... the versatility the industry ...
Medicine Products: